A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Brief description of study

This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03519945

Start Over

Academisch Medisch Centrum

Amsterdam, Netherlands

5.88miles

View all locations

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Brief description of study

Academisch Medisch Centrum

Volunteer Sign-up